nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Paresis—Temozolomide—melanoma	0.0208	0.0236	CcSEcCtD
Glimepiride—Disorder sight—Temozolomide—melanoma	0.016	0.0181	CcSEcCtD
Glimepiride—Vasculitis—Vemurafenib—melanoma	0.0152	0.0173	CcSEcCtD
Glimepiride—Reaction gastrointestinal—Docetaxel—melanoma	0.0151	0.0172	CcSEcCtD
Glimepiride—Eruption—Dactinomycin—melanoma	0.0137	0.0155	CcSEcCtD
Glimepiride—Cerebration impaired—Temozolomide—melanoma	0.0129	0.0147	CcSEcCtD
Glimepiride—Aphasia—Carmustine—melanoma	0.0121	0.0138	CcSEcCtD
Glimepiride—Aphasia—Temozolomide—melanoma	0.0117	0.0133	CcSEcCtD
Glimepiride—Pain in extremity—Vemurafenib—melanoma	0.0108	0.0122	CcSEcCtD
Glimepiride—Aggression—Bleomycin—melanoma	0.0102	0.0116	CcSEcCtD
Glimepiride—Cholestasis—Temozolomide—melanoma	0.01	0.0113	CcSEcCtD
Glimepiride—Gliclazide—VEGFA—melanoma	0.00987	0.197	CrCbGaD
Glimepiride—Chlorpropamide—SLC15A2—melanoma	0.00958	0.191	CrCbGaD
Glimepiride—Tolbutamide—SLC15A2—melanoma	0.00934	0.186	CrCbGaD
Glimepiride—Eosinophilia—Vemurafenib—melanoma	0.00923	0.0105	CcSEcCtD
Glimepiride—Speech disorder—Carmustine—melanoma	0.00914	0.0104	CcSEcCtD
Glimepiride—Accidental injury—Carmustine—melanoma	0.00888	0.0101	CcSEcCtD
Glimepiride—Speech disorder—Temozolomide—melanoma	0.00883	0.01	CcSEcCtD
Glimepiride—Disturbance in attention—Temozolomide—melanoma	0.00877	0.00995	CcSEcCtD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCB5—melanoma	0.00852	0.125	CbGpPWpGaD
Glimepiride—Photosensitivity reaction—Vemurafenib—melanoma	0.00851	0.00966	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Temozolomide—melanoma	0.00835	0.00948	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00824	0.00935	CcSEcCtD
Glimepiride—Eruption—Docetaxel—melanoma	0.00821	0.00932	CcSEcCtD
Glimepiride—Aplastic anaemia—Dactinomycin—melanoma	0.00788	0.00895	CcSEcCtD
Glimepiride—Glipizide—PPARG—melanoma	0.00758	0.151	CrCbGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—CPT1C—melanoma	0.00726	0.106	CbGpPWpGaD
Glimepiride—Coma—Carmustine—melanoma	0.00718	0.00815	CcSEcCtD
Glimepiride—Aplastic anaemia—Temozolomide—melanoma	0.00713	0.00809	CcSEcCtD
Glimepiride—Injury—Bleomycin—melanoma	0.00711	0.00807	CcSEcCtD
Glimepiride—Erythema multiforme—Vemurafenib—melanoma	0.00706	0.00801	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—CPT1C—melanoma	0.00704	0.103	CbGpPWpGaD
Glimepiride—Mental disability—Carmustine—melanoma	0.00682	0.00774	CcSEcCtD
Glimepiride—Hepatic failure—Dactinomycin—melanoma	0.00678	0.0077	CcSEcCtD
Glimepiride—Cerebrovascular accident—Bleomycin—melanoma	0.00667	0.00757	CcSEcCtD
Glimepiride—Mental disability—Temozolomide—melanoma	0.00659	0.00748	CcSEcCtD
Glimepiride—Diabetes mellitus—Carmustine—melanoma	0.00656	0.00744	CcSEcCtD
Glimepiride—Erythema—Vemurafenib—melanoma	0.0065	0.00737	CcSEcCtD
Glimepiride—Malnutrition—Vemurafenib—melanoma	0.0065	0.00737	CcSEcCtD
Glimepiride—Glyburide—SLC15A2—melanoma	0.00647	0.129	CrCbGaD
Glimepiride—Injury—Carmustine—melanoma	0.00621	0.00704	CcSEcCtD
Glimepiride—Hepatic failure—Temozolomide—melanoma	0.00614	0.00696	CcSEcCtD
Glimepiride—Hot flush—Temozolomide—melanoma	0.00589	0.00669	CcSEcCtD
Glimepiride—Menopausal symptoms—Temozolomide—melanoma	0.00584	0.00663	CcSEcCtD
Glimepiride—Hyponatraemia—Carmustine—melanoma	0.00573	0.0065	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Docetaxel—melanoma	0.00555	0.0063	CcSEcCtD
Glimepiride—Pancytopenia—Bleomycin—melanoma	0.00537	0.00609	CcSEcCtD
Glimepiride—Anaphylactic shock—Vemurafenib—melanoma	0.0053	0.00602	CcSEcCtD
Glimepiride—Pancytopenia—Dactinomycin—melanoma	0.005	0.00568	CcSEcCtD
Glimepiride—Hypotension—Vemurafenib—melanoma	0.00495	0.00562	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Temozolomide—melanoma	0.00486	0.00552	CcSEcCtD
Glimepiride—Abdominal distension—Temozolomide—melanoma	0.0048	0.00544	CcSEcCtD
Glimepiride—Pancytopenia—Carmustine—melanoma	0.00468	0.00531	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00466	0.00528	CcSEcCtD
Glimepiride—Sweating increased—Temozolomide—melanoma	0.00464	0.00527	CcSEcCtD
Glimepiride—Decreased appetite—Vemurafenib—melanoma	0.00461	0.00523	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Vemurafenib—melanoma	0.00458	0.00519	CcSEcCtD
Glimepiride—Fatigue—Vemurafenib—melanoma	0.00457	0.00519	CcSEcCtD
Glimepiride—Pancytopenia—Temozolomide—melanoma	0.00453	0.00514	CcSEcCtD
Glimepiride—Pollakiuria—Temozolomide—melanoma	0.0044	0.005	CcSEcCtD
Glimepiride—Agranulocytosis—Dactinomycin—melanoma	0.00438	0.00497	CcSEcCtD
Glimepiride—Photosensitivity reaction—Temozolomide—melanoma	0.00435	0.00494	CcSEcCtD
Glimepiride—Weight increased—Temozolomide—melanoma	0.00434	0.00492	CcSEcCtD
Glimepiride—Hepatitis—Dactinomycin—melanoma	0.00422	0.00479	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00421	0.00478	CcSEcCtD
Glimepiride—Hepatic failure—Docetaxel—melanoma	0.00408	0.00463	CcSEcCtD
Glimepiride—Erythema multiforme—Dactinomycin—melanoma	0.00399	0.00452	CcSEcCtD
Glimepiride—Erythema—Bleomycin—melanoma	0.00394	0.00447	CcSEcCtD
Glimepiride—Hot flush—Docetaxel—melanoma	0.00392	0.00445	CcSEcCtD
Glimepiride—Hypersensitivity—Vemurafenib—melanoma	0.00391	0.00443	CcSEcCtD
Glimepiride—Menopausal symptoms—Docetaxel—melanoma	0.00389	0.00441	CcSEcCtD
Glimepiride—Dermatitis bullous—Docetaxel—melanoma	0.00384	0.00435	CcSEcCtD
Glimepiride—Hepatitis—Temozolomide—melanoma	0.00381	0.00433	CcSEcCtD
Glimepiride—Asthenia—Vemurafenib—melanoma	0.0038	0.00432	CcSEcCtD
Glimepiride—Visual impairment—Carmustine—melanoma	0.0038	0.00432	CcSEcCtD
Glimepiride—Pruritus—Vemurafenib—melanoma	0.00375	0.00426	CcSEcCtD
Glimepiride—Hyponatraemia—Docetaxel—melanoma	0.00368	0.00418	CcSEcCtD
Glimepiride—Visual impairment—Temozolomide—melanoma	0.00368	0.00417	CcSEcCtD
Glimepiride—Erythema—Dactinomycin—melanoma	0.00367	0.00417	CcSEcCtD
Glimepiride—Pain in extremity—Docetaxel—melanoma	0.00367	0.00416	CcSEcCtD
Glimepiride—Anaemia—Bleomycin—melanoma	0.00364	0.00413	CcSEcCtD
Glimepiride—Diarrhoea—Vemurafenib—melanoma	0.00363	0.00412	CcSEcCtD
Glimepiride—Erythema multiforme—Temozolomide—melanoma	0.00361	0.00409	CcSEcCtD
Glimepiride—Arrhythmia—Carmustine—melanoma	0.00353	0.004	CcSEcCtD
Glimepiride—Leukopenia—Bleomycin—melanoma	0.00352	0.004	CcSEcCtD
Glimepiride—Dizziness—Vemurafenib—melanoma	0.00351	0.00398	CcSEcCtD
Glimepiride—Erythema—Carmustine—melanoma	0.00344	0.0039	CcSEcCtD
Glimepiride—Malnutrition—Carmustine—melanoma	0.00344	0.0039	CcSEcCtD
Glimepiride—Anaemia—Dactinomycin—melanoma	0.00339	0.00385	CcSEcCtD
Glimepiride—Vomiting—Vemurafenib—melanoma	0.00337	0.00383	CcSEcCtD
Glimepiride—Rash—Vemurafenib—melanoma	0.00334	0.00379	CcSEcCtD
Glimepiride—Dermatitis—Vemurafenib—melanoma	0.00334	0.00379	CcSEcCtD
Glimepiride—Headache—Vemurafenib—melanoma	0.00332	0.00377	CcSEcCtD
Glimepiride—Erythema—Temozolomide—melanoma	0.00332	0.00377	CcSEcCtD
Glimepiride—Malnutrition—Temozolomide—melanoma	0.00332	0.00377	CcSEcCtD
Glimepiride—Leukopenia—Dactinomycin—melanoma	0.00329	0.00373	CcSEcCtD
Glimepiride—Confusional state—Bleomycin—melanoma	0.00324	0.00368	CcSEcCtD
Glimepiride—Vision blurred—Carmustine—melanoma	0.00324	0.00367	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Docetaxel—melanoma	0.00323	0.00367	CcSEcCtD
Glimepiride—Tremor—Carmustine—melanoma	0.00322	0.00365	CcSEcCtD
Glimepiride—Anaphylactic shock—Bleomycin—melanoma	0.00321	0.00365	CcSEcCtD
Glimepiride—Anaemia—Carmustine—melanoma	0.00318	0.0036	CcSEcCtD
Glimepiride—Agitation—Carmustine—melanoma	0.00316	0.00358	CcSEcCtD
Glimepiride—Nausea—Vemurafenib—melanoma	0.00315	0.00357	CcSEcCtD
Glimepiride—Thrombocytopenia—Bleomycin—melanoma	0.00315	0.00357	CcSEcCtD
Glimepiride—Vision blurred—Temozolomide—melanoma	0.00313	0.00355	CcSEcCtD
Glimepiride—Tremor—Temozolomide—melanoma	0.00311	0.00353	CcSEcCtD
Glimepiride—Angina pectoris—Docetaxel—melanoma	0.00309	0.0035	CcSEcCtD
Glimepiride—Leukopenia—Carmustine—melanoma	0.00308	0.00349	CcSEcCtD
Glimepiride—Anaemia—Temozolomide—melanoma	0.00307	0.00348	CcSEcCtD
Glimepiride—Anorexia—Bleomycin—melanoma	0.00306	0.00347	CcSEcCtD
Glimepiride—Agitation—Temozolomide—melanoma	0.00305	0.00346	CcSEcCtD
Glimepiride—Angioedema—Temozolomide—melanoma	0.00303	0.00344	CcSEcCtD
Glimepiride—Pancytopenia—Docetaxel—melanoma	0.00301	0.00341	CcSEcCtD
Glimepiride—Hypotension—Bleomycin—melanoma	0.003	0.00341	CcSEcCtD
Glimepiride—Convulsion—Carmustine—melanoma	0.00298	0.00338	CcSEcCtD
Glimepiride—Leukopenia—Temozolomide—melanoma	0.00297	0.00337	CcSEcCtD
Glimepiride—Hypertension—Carmustine—melanoma	0.00297	0.00337	CcSEcCtD
Glimepiride—Palpitations—Temozolomide—melanoma	0.00293	0.00333	CcSEcCtD
Glimepiride—Thrombocytopenia—Dactinomycin—melanoma	0.00293	0.00333	CcSEcCtD
Glimepiride—Anxiety—Carmustine—melanoma	0.00292	0.00331	CcSEcCtD
Glimepiride—Paraesthesia—Bleomycin—melanoma	0.00288	0.00327	CcSEcCtD
Glimepiride—Weight increased—Docetaxel—melanoma	0.00288	0.00327	CcSEcCtD
Glimepiride—Convulsion—Temozolomide—melanoma	0.00288	0.00326	CcSEcCtD
Glimepiride—Hypertension—Temozolomide—melanoma	0.00287	0.00325	CcSEcCtD
Glimepiride—Dyspnoea—Bleomycin—melanoma	0.00286	0.00325	CcSEcCtD
Glimepiride—Anorexia—Dactinomycin—melanoma	0.00286	0.00324	CcSEcCtD
Glimepiride—Confusional state—Carmustine—melanoma	0.00283	0.00321	CcSEcCtD
Glimepiride—Anxiety—Temozolomide—melanoma	0.00282	0.0032	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Docetaxel—melanoma	0.0028	0.00318	CcSEcCtD
Glimepiride—Decreased appetite—Bleomycin—melanoma	0.00279	0.00317	CcSEcCtD
Glimepiride—Dry mouth—Temozolomide—melanoma	0.00276	0.00314	CcSEcCtD
Glimepiride—Jaundice—Docetaxel—melanoma	0.00275	0.00313	CcSEcCtD
Glimepiride—Thrombocytopenia—Carmustine—melanoma	0.00275	0.00312	CcSEcCtD
Glimepiride—Tachycardia—Carmustine—melanoma	0.00274	0.00311	CcSEcCtD
Glimepiride—Confusional state—Temozolomide—melanoma	0.00273	0.0031	CcSEcCtD
Glimepiride—Anaphylactic shock—Temozolomide—melanoma	0.00271	0.00307	CcSEcCtD
Glimepiride—Anorexia—Carmustine—melanoma	0.00267	0.00303	CcSEcCtD
Glimepiride—Thrombocytopenia—Temozolomide—melanoma	0.00265	0.00301	CcSEcCtD
Glimepiride—Gliclazide—ALB—melanoma	0.00265	0.0528	CrCbGaD
Glimepiride—Feeling abnormal—Bleomycin—melanoma	0.00265	0.003	CcSEcCtD
Glimepiride—Agranulocytosis—Docetaxel—melanoma	0.00264	0.00299	CcSEcCtD
Glimepiride—Hypotension—Carmustine—melanoma	0.00262	0.00297	CcSEcCtD
Glimepiride—Hyperhidrosis—Temozolomide—melanoma	0.00262	0.00297	CcSEcCtD
Glimepiride—Decreased appetite—Dactinomycin—melanoma	0.0026	0.00296	CcSEcCtD
Glimepiride—Fatigue—Dactinomycin—melanoma	0.00258	0.00293	CcSEcCtD
Glimepiride—Anorexia—Temozolomide—melanoma	0.00258	0.00293	CcSEcCtD
Glimepiride—Urticaria—Bleomycin—melanoma	0.00255	0.0029	CcSEcCtD
Glimepiride—Hepatitis—Docetaxel—melanoma	0.00254	0.00288	CcSEcCtD
Glimepiride—Insomnia—Carmustine—melanoma	0.00254	0.00288	CcSEcCtD
Glimepiride—Paraesthesia—Carmustine—melanoma	0.00252	0.00286	CcSEcCtD
Glimepiride—Dyspnoea—Carmustine—melanoma	0.0025	0.00284	CcSEcCtD
Glimepiride—Somnolence—Carmustine—melanoma	0.00249	0.00283	CcSEcCtD
Glimepiride—Feeling abnormal—Dactinomycin—melanoma	0.00247	0.0028	CcSEcCtD
Glimepiride—Insomnia—Temozolomide—melanoma	0.00245	0.00278	CcSEcCtD
Glimepiride—Gastrointestinal pain—Dactinomycin—melanoma	0.00245	0.00278	CcSEcCtD
Glimepiride—Visual impairment—Docetaxel—melanoma	0.00244	0.00277	CcSEcCtD
Glimepiride—Decreased appetite—Carmustine—melanoma	0.00244	0.00277	CcSEcCtD
Glimepiride—Paraesthesia—Temozolomide—melanoma	0.00243	0.00276	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Carmustine—melanoma	0.00242	0.00275	CcSEcCtD
Glimepiride—Dyspnoea—Temozolomide—melanoma	0.00242	0.00274	CcSEcCtD
Glimepiride—Somnolence—Temozolomide—melanoma	0.00241	0.00273	CcSEcCtD
Glimepiride—Erythema multiforme—Docetaxel—melanoma	0.0024	0.00272	CcSEcCtD
Glimepiride—Dyspepsia—Temozolomide—melanoma	0.00239	0.00271	CcSEcCtD
Glimepiride—Abdominal pain—Dactinomycin—melanoma	0.00237	0.00269	CcSEcCtD
Glimepiride—Hypersensitivity—Bleomycin—melanoma	0.00237	0.00269	CcSEcCtD
Glimepiride—Decreased appetite—Temozolomide—melanoma	0.00236	0.00267	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Temozolomide—melanoma	0.00234	0.00265	CcSEcCtD
Glimepiride—Fatigue—Temozolomide—melanoma	0.00234	0.00265	CcSEcCtD
Glimepiride—Feeling abnormal—Carmustine—melanoma	0.00231	0.00262	CcSEcCtD
Glimepiride—Asthenia—Bleomycin—melanoma	0.0023	0.00262	CcSEcCtD
Glimepiride—Gastrointestinal pain—Carmustine—melanoma	0.00229	0.0026	CcSEcCtD
Glimepiride—Pruritus—Bleomycin—melanoma	0.00227	0.00258	CcSEcCtD
Glimepiride—Arrhythmia—Docetaxel—melanoma	0.00227	0.00257	CcSEcCtD
Glimepiride—Feeling abnormal—Temozolomide—melanoma	0.00223	0.00253	CcSEcCtD
Glimepiride—Abdominal pain—Carmustine—melanoma	0.00222	0.00252	CcSEcCtD
Glimepiride—Gastrointestinal pain—Temozolomide—melanoma	0.00222	0.00251	CcSEcCtD
Glimepiride—Erythema—Docetaxel—melanoma	0.00221	0.00251	CcSEcCtD
Glimepiride—Malnutrition—Docetaxel—melanoma	0.00221	0.00251	CcSEcCtD
Glimepiride—Hypersensitivity—Dactinomycin—melanoma	0.00221	0.0025	CcSEcCtD
Glimepiride—Urticaria—Temozolomide—melanoma	0.00215	0.00244	CcSEcCtD
Glimepiride—Asthenia—Dactinomycin—melanoma	0.00215	0.00244	CcSEcCtD
Glimepiride—Abdominal pain—Temozolomide—melanoma	0.00214	0.00243	CcSEcCtD
Glimepiride—Hypersensitivity—Carmustine—melanoma	0.00207	0.00234	CcSEcCtD
Glimepiride—Diarrhoea—Dactinomycin—melanoma	0.00205	0.00233	CcSEcCtD
Glimepiride—Vomiting—Bleomycin—melanoma	0.00204	0.00232	CcSEcCtD
Glimepiride—Anaemia—Docetaxel—melanoma	0.00204	0.00232	CcSEcCtD
Glimepiride—Rash—Bleomycin—melanoma	0.00203	0.0023	CcSEcCtD
Glimepiride—Dermatitis—Bleomycin—melanoma	0.00202	0.0023	CcSEcCtD
Glimepiride—Asthenia—Carmustine—melanoma	0.00201	0.00228	CcSEcCtD
Glimepiride—Hypersensitivity—Temozolomide—melanoma	0.002	0.00227	CcSEcCtD
Glimepiride—Leukopenia—Docetaxel—melanoma	0.00198	0.00224	CcSEcCtD
Glimepiride—Chlorpropamide—ABCB1—melanoma	0.00197	0.0392	CrCbGaD
Glimepiride—Palpitations—Docetaxel—melanoma	0.00195	0.00221	CcSEcCtD
Glimepiride—Asthenia—Temozolomide—melanoma	0.00194	0.00221	CcSEcCtD
Glimepiride—Loss of consciousness—Docetaxel—melanoma	0.00194	0.0022	CcSEcCtD
Glimepiride—Diarrhoea—Carmustine—melanoma	0.00192	0.00218	CcSEcCtD
Glimepiride—Pruritus—Temozolomide—melanoma	0.00192	0.00218	CcSEcCtD
Glimepiride—Convulsion—Docetaxel—melanoma	0.00191	0.00217	CcSEcCtD
Glimepiride—Nausea—Bleomycin—melanoma	0.00191	0.00217	CcSEcCtD
Glimepiride—Hypertension—Docetaxel—melanoma	0.00191	0.00216	CcSEcCtD
Glimepiride—Vomiting—Dactinomycin—melanoma	0.00191	0.00216	CcSEcCtD
Glimepiride—Rash—Dactinomycin—melanoma	0.00189	0.00214	CcSEcCtD
Glimepiride—Dizziness—Carmustine—melanoma	0.00185	0.0021	CcSEcCtD
Glimepiride—Diarrhoea—Temozolomide—melanoma	0.00185	0.0021	CcSEcCtD
Glimepiride—Dry mouth—Docetaxel—melanoma	0.00184	0.00209	CcSEcCtD
Glimepiride—Confusional state—Docetaxel—melanoma	0.00182	0.00206	CcSEcCtD
Glimepiride—Anaphylactic shock—Docetaxel—melanoma	0.0018	0.00204	CcSEcCtD
Glimepiride—Dizziness—Temozolomide—melanoma	0.00179	0.00203	CcSEcCtD
Glimepiride—Vomiting—Carmustine—melanoma	0.00178	0.00202	CcSEcCtD
Glimepiride—Nausea—Dactinomycin—melanoma	0.00178	0.00202	CcSEcCtD
Glimepiride—Shock—Docetaxel—melanoma	0.00177	0.00201	CcSEcCtD
Glimepiride—Rash—Carmustine—melanoma	0.00177	0.00201	CcSEcCtD
Glimepiride—Dermatitis—Carmustine—melanoma	0.00177	0.002	CcSEcCtD
Glimepiride—Thrombocytopenia—Docetaxel—melanoma	0.00176	0.002	CcSEcCtD
Glimepiride—Tachycardia—Docetaxel—melanoma	0.00176	0.002	CcSEcCtD
Glimepiride—Headache—Carmustine—melanoma	0.00176	0.00199	CcSEcCtD
Glimepiride—Vomiting—Temozolomide—melanoma	0.00172	0.00196	CcSEcCtD
Glimepiride—Anorexia—Docetaxel—melanoma	0.00172	0.00195	CcSEcCtD
Glimepiride—Rash—Temozolomide—melanoma	0.00171	0.00194	CcSEcCtD
Glimepiride—Dermatitis—Temozolomide—melanoma	0.00171	0.00194	CcSEcCtD
Glimepiride—Headache—Temozolomide—melanoma	0.0017	0.00193	CcSEcCtD
Glimepiride—Hypotension—Docetaxel—melanoma	0.00168	0.00191	CcSEcCtD
Glimepiride—Nausea—Carmustine—melanoma	0.00167	0.00189	CcSEcCtD
Glimepiride—Insomnia—Docetaxel—melanoma	0.00163	0.00185	CcSEcCtD
Glimepiride—Paraesthesia—Docetaxel—melanoma	0.00162	0.00184	CcSEcCtD
Glimepiride—Nausea—Temozolomide—melanoma	0.00161	0.00183	CcSEcCtD
Glimepiride—Dyspnoea—Docetaxel—melanoma	0.00161	0.00182	CcSEcCtD
Glimepiride—Somnolence—Docetaxel—melanoma	0.0016	0.00182	CcSEcCtD
Glimepiride—Dyspepsia—Docetaxel—melanoma	0.00159	0.0018	CcSEcCtD
Glimepiride—Decreased appetite—Docetaxel—melanoma	0.00157	0.00178	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Docetaxel—melanoma	0.00156	0.00177	CcSEcCtD
Glimepiride—Fatigue—Docetaxel—melanoma	0.00155	0.00176	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—SLC6A11—melanoma	0.00149	0.0217	CbGpPWpGaD
Glimepiride—Feeling abnormal—Docetaxel—melanoma	0.00149	0.00169	CcSEcCtD
Glimepiride—Gastrointestinal pain—Docetaxel—melanoma	0.00147	0.00167	CcSEcCtD
Glimepiride—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—melanoma	0.00146	0.0213	CbGpPWpGaD
Glimepiride—Abdominal pain—Docetaxel—melanoma	0.00142	0.00162	CcSEcCtD
Glimepiride—Glyburide—ALB—melanoma	0.00139	0.0278	CrCbGaD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCB1—melanoma	0.00136	0.0199	CbGpPWpGaD
Glimepiride—Glyburide—ABCB1—melanoma	0.00133	0.0265	CrCbGaD
Glimepiride—Hypersensitivity—Docetaxel—melanoma	0.00133	0.00151	CcSEcCtD
Glimepiride—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—melanoma	0.00133	0.0194	CbGpPWpGaD
Glimepiride—Asthenia—Docetaxel—melanoma	0.00129	0.00147	CcSEcCtD
Glimepiride—Pruritus—Docetaxel—melanoma	0.00128	0.00145	CcSEcCtD
Glimepiride—Diarrhoea—Docetaxel—melanoma	0.00123	0.0014	CcSEcCtD
Glimepiride—Dizziness—Docetaxel—melanoma	0.00119	0.00135	CcSEcCtD
Glimepiride—Vomiting—Docetaxel—melanoma	0.00115	0.0013	CcSEcCtD
Glimepiride—Rash—Docetaxel—melanoma	0.00114	0.00129	CcSEcCtD
Glimepiride—Dermatitis—Docetaxel—melanoma	0.00114	0.00129	CcSEcCtD
Glimepiride—Headache—Docetaxel—melanoma	0.00113	0.00128	CcSEcCtD
Glimepiride—Nausea—Docetaxel—melanoma	0.00107	0.00121	CcSEcCtD
Glimepiride—ABCC8—Regulation of insulin secretion—GNA11—melanoma	0.00101	0.0148	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—GNA11—melanoma	0.000981	0.0143	CbGpPWpGaD
Glimepiride—ABCC8—Regulation of insulin secretion—GNAQ—melanoma	0.000941	0.0137	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—GNAQ—melanoma	0.000912	0.0133	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—GRIN2A—melanoma	0.000909	0.0133	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCB5—melanoma	0.000891	0.013	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—GNA11—melanoma	0.000796	0.0116	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—FASN—melanoma	0.000779	0.0114	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—GNA11—melanoma	0.000772	0.0113	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—MAPK1—melanoma	0.000761	0.0111	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—SLC6A11—melanoma	0.000761	0.0111	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—FASN—melanoma	0.000755	0.011	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—GNAQ—melanoma	0.00074	0.0108	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—SLC6A11—melanoma	0.000738	0.0108	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—melanoma	0.000727	0.0106	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—TNF—melanoma	0.000725	0.0106	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—GNAQ—melanoma	0.000717	0.0105	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—melanoma	0.000705	0.0103	CbGpPWpGaD
Glimepiride—ABCC8—Regulation of insulin secretion—PRKCA—melanoma	0.000684	0.00999	CbGpPWpGaD
Glimepiride—CYP2C9—Tamoxifen metabolism—CYP1B1—melanoma	0.000673	0.00983	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—PRKCA—melanoma	0.000663	0.00968	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ARL2—melanoma	0.000617	0.00902	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—PRKCA—melanoma	0.000538	0.00785	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—PRKCA—melanoma	0.000521	0.00761	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—PRKCA—melanoma	0.000478	0.00698	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000468	0.00683	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—GRIN2A—melanoma	0.000465	0.00679	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—GRIN2A—melanoma	0.000451	0.00658	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00045	0.00658	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—UGT2B10—melanoma	0.000446	0.00652	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000409	0.00597	CbGpPWpGaD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000396	0.00578	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000377	0.00551	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000376	0.0055	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—BRAF—melanoma	0.000352	0.00514	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000345	0.00504	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000341	0.00498	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—CYP1B1—melanoma	0.000336	0.00491	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.00032	0.00467	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ACER3—melanoma	0.000316	0.00462	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.00031	0.00453	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ACER3—melanoma	0.000307	0.00448	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—MDM2—melanoma	0.000295	0.0043	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000291	0.00425	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—UGT2B10—melanoma	0.000289	0.00422	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000287	0.00419	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—AKR1B10—melanoma	0.000284	0.00414	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—UGT2B10—melanoma	0.00028	0.0041	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.00028	0.00409	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HS3ST5—melanoma	0.000269	0.00393	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000262	0.00383	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HS3ST5—melanoma	0.000261	0.00381	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—PRKCA—melanoma	0.000244	0.00357	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—PRKCA—melanoma	0.000237	0.00346	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000236	0.00344	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLCB4—melanoma	0.000204	0.00298	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—MAPK1—melanoma	0.000201	0.00294	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLCB4—melanoma	0.000198	0.00289	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIP4K2A—melanoma	0.000192	0.0028	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC6A11—melanoma	0.000192	0.0028	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000187	0.00274	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000187	0.00273	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTAP—melanoma	0.000186	0.00272	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIP4K2A—melanoma	0.000186	0.00271	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC6A11—melanoma	0.000186	0.00271	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTAP—melanoma	0.000181	0.00264	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—BRAF—melanoma	0.00018	0.00262	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—BRAF—melanoma	0.000174	0.00255	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LUM—melanoma	0.000166	0.00243	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PHGDH—melanoma	0.000166	0.00243	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HPSE—melanoma	0.000163	0.00238	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—HRAS—melanoma	0.000162	0.00236	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PHGDH—melanoma	0.000161	0.00235	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LUM—melanoma	0.000161	0.00235	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CUBN—melanoma	0.00016	0.00234	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HPSE—melanoma	0.000158	0.00231	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CUBN—melanoma	0.000155	0.00226	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SDHD—melanoma	0.000154	0.00226	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—BSG—melanoma	0.000154	0.00226	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CSPG4—melanoma	0.000154	0.00226	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	0.000152	0.00221	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—MDM2—melanoma	0.000151	0.0022	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SDHD—melanoma	0.00015	0.00219	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—BSG—melanoma	0.00015	0.00219	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CSPG4—melanoma	0.00015	0.00219	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GPAM—melanoma	0.00015	0.00218	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP17A1—melanoma	0.000149	0.00217	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	0.000147	0.00214	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—MDM2—melanoma	0.000146	0.00213	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GPAM—melanoma	0.000145	0.00212	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCB1—melanoma	0.000143	0.00208	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLA2G6—melanoma	0.000127	0.00186	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP1B1—melanoma	0.000125	0.00183	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	0.000123	0.0018	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLA2G6—melanoma	0.000123	0.0018	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—VCAN—melanoma	0.000114	0.00167	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000114	0.00166	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—VCAN—melanoma	0.000111	0.00162	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—MAPK1—melanoma	0.000103	0.0015	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—MAPK1—melanoma	9.98e-05	0.00146	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP17A1—melanoma	9.64e-05	0.00141	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	9.47e-05	0.00138	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP17A1—melanoma	9.34e-05	0.00136	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GNA11—melanoma	9.1e-05	0.00133	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—melanoma	8.92e-05	0.0013	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FASN—melanoma	8.91e-05	0.0013	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	8.86e-05	0.00129	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GNA11—melanoma	8.82e-05	0.00129	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC5A5—melanoma	8.76e-05	0.00128	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FASN—melanoma	8.64e-05	0.00126	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC5A5—melanoma	8.49e-05	0.00124	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GNAQ—melanoma	8.46e-05	0.00124	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CD44—melanoma	8.46e-05	0.00124	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACER3—melanoma	8.34e-05	0.00122	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—HRAS—melanoma	8.26e-05	0.00121	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GNAQ—melanoma	8.2e-05	0.0012	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CD44—melanoma	8.2e-05	0.0012	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1B1—melanoma	8.11e-05	0.00118	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—HRAS—melanoma	8.01e-05	0.00117	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1B1—melanoma	7.86e-05	0.00115	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—UGT2B10—melanoma	7.63e-05	0.00111	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	7.53e-05	0.0011	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HS3ST5—melanoma	7.09e-05	0.00104	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCB1—melanoma	6.68e-05	0.000976	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCB1—melanoma	6.48e-05	0.000946	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PRKCA—melanoma	6.15e-05	0.000898	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ERCC2—melanoma	6.1e-05	0.00089	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PRKCA—melanoma	5.96e-05	0.000871	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ERCC2—melanoma	5.91e-05	0.000863	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.71e-05	0.000834	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLCB4—melanoma	5.38e-05	0.000785	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	5.28e-05	0.000771	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIP4K2A—melanoma	5.06e-05	0.000738	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC6A11—melanoma	5.06e-05	0.000738	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTAP—melanoma	4.92e-05	0.000718	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CG—melanoma	4.81e-05	0.000703	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.81e-05	0.000702	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CG—melanoma	4.67e-05	0.000682	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARG—melanoma	4.65e-05	0.000679	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARG—melanoma	4.51e-05	0.000658	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LUM—melanoma	4.38e-05	0.00064	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PHGDH—melanoma	4.38e-05	0.00064	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HPSE—melanoma	4.3e-05	0.000628	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CD—melanoma	4.23e-05	0.000618	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CUBN—melanoma	4.22e-05	0.000616	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—melanoma	4.18e-05	0.00061	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CD—melanoma	4.1e-05	0.000599	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SDHD—melanoma	4.07e-05	0.000595	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—BSG—melanoma	4.07e-05	0.000595	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CSPG4—melanoma	4.07e-05	0.000595	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—melanoma	4.05e-05	0.000592	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPAM—melanoma	3.95e-05	0.000576	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CB—melanoma	3.69e-05	0.000539	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—melanoma	3.66e-05	0.000534	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CB—melanoma	3.58e-05	0.000523	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—melanoma	3.54e-05	0.000518	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLA2G6—melanoma	3.36e-05	0.00049	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTEN—melanoma	3.19e-05	0.000466	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTEN—melanoma	3.09e-05	0.000452	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—VCAN—melanoma	3.01e-05	0.00044	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.85e-05	0.000417	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.75e-05	0.000402	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP17A1—melanoma	2.54e-05	0.000371	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.51e-05	0.000366	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.48e-05	0.000362	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GNA11—melanoma	2.4e-05	0.000351	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FASN—melanoma	2.35e-05	0.000343	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC5A5—melanoma	2.31e-05	0.000338	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CA—melanoma	2.25e-05	0.000328	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GNAQ—melanoma	2.23e-05	0.000326	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CD44—melanoma	2.23e-05	0.000326	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.19e-05	0.000319	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CA—melanoma	2.18e-05	0.000319	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.17e-05	0.000316	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1B1—melanoma	2.14e-05	0.000313	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.89e-05	0.000276	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—melanoma	1.84e-05	0.000268	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—melanoma	1.78e-05	0.00026	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCB1—melanoma	1.76e-05	0.000257	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PRKCA—melanoma	1.62e-05	0.000237	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ERCC2—melanoma	1.61e-05	0.000235	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.33e-05	0.000195	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CG—melanoma	1.27e-05	0.000186	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARG—melanoma	1.23e-05	0.000179	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CD—melanoma	1.12e-05	0.000163	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—melanoma	1.1e-05	0.000161	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CB—melanoma	9.74e-06	0.000142	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—melanoma	9.65e-06	0.000141	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTEN—melanoma	8.41e-06	0.000123	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CA—melanoma	5.94e-06	8.67e-05	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—melanoma	4.85e-06	7.08e-05	CbGpPWpGaD
